 |
 |
||
 |
 |
 |
 |
||||
 |
 |
 |
 |
About the Inogen G2
The 12-Cell Rechargeable Lithium Ion Battery will power the G2 without connection to an external power supply. When fully charged, the 12-Cell battery will provide up to 4 hours of operation. The 24-Cell battery will provide up to 8 hours of operation. The battery will recharge when it is properly installed in the G2 and the connector is connected to an AC or DC power supply. The Inogen Universal Power Supply is used to power the Inogen G2 concentrator from an AC or DC power source. This allows the patient to power the concentrator in their home, vehicle or any other place where AC or DC power is available. The Inogen G2 Universal Power Supply is specifically designed for use with the Inogen G2 Oxygen Concentrator. The Universal Power Supply provides the percise current and voltage required to safely power the Inogen G2 and is designed to operatefrom secified AC and DC power sources. When used withAC power sources, the supply automatically adapts to input voltages from 100V to 240V permitting use with most power sources thoughout the world. The Universal Power Supply will charge the Inogen G2 Battery when used with AC input power or when used with a DC power supply, such as one found in your car. Due to aircraft power limitations, the Universal Power Supply cannot be used to charge the Inogen G2 battery when used in an aircraft. The Inogen G2 is smart with it’s clean no fuss appearance and it’s smooth lines. The optional purchase of the extra 8 hour capacity battery would give you up to an amasing 12 hours of battery life, so no worrying you won’t have enough oxygen for your day trips. Operating the Inogen G2 is easy with it’s simple LCD display. It’s built to withstand long term and heavy duty use day and night. Altough the Inogen G2 is small and lightweight, it comes with a cart for ease of use when you need it.
About Inogen
Inogen was founded in 2001 to improve quality of life and increase freedom and independence for oxygen therapy users, predominantly Chronic Obstructive Pulmonary Disease (COPD) patients. COPD is the fourth leading cause of death in the United States, and the only major disease with an ever increasing death rate. By 2020 COPD is predicted to become the third leading cause of death worldwide. COPD affects an estimated 30 million people in the US and over 100 million worldwide.
Supplemental oxygen has been proven to reduce the symptoms of the disease and extend life expectancy of patients with COPD. Despite the clear benefits of oxygen in extending life and maintaining health, many patients find it difficult to comply with therapy because currently available therapy devices inhibit their ability to lead an active life. Today’s more active patient is refusing to be restricted in their lifestyle by being tethered to antiquated, stationary machines.
